Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind, parallel-group, placebo-controlled trial evaluating cetirizine HCl syrup and loratadine syrup against placebo in children with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine HCl syrup (cetirizine hydrochloride)
  • Loratadine syrup (loratadine)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Allergic Rhinitis, Hay Fever | Phase 4 | Status: COMPLETED